Ocean Biomedical Stock Probability of Future Stock Price Finishing Over 0.72
| OCEA Stock | 0.72 0.01 1.41% |
Ocean |
Ocean Biomedical Target Price Odds to finish over 0.72
The tendency of Ocean Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.72 | 90 days | 0.72 | roughly 97.0 |
Based on a normal probability distribution, the odds of Ocean Biomedical to move above the current price in 90 days from now is roughly 97.0 (This Ocean Biomedical probability density function shows the probability of Ocean Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Ocean Biomedical has a beta of 0.37. This indicates as returns on the market go up, Ocean Biomedical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ocean Biomedical will be expected to be much smaller as well. Additionally Ocean Biomedical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Ocean Biomedical Price Density |
| Price |
Predictive Modules for Ocean Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ocean Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocean Biomedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ocean Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ocean Biomedical is not an exception. The market had few large corrections towards the Ocean Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ocean Biomedical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ocean Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.56 | |
β | Beta against Dow Jones | 0.37 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.12 |
Ocean Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ocean Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ocean Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ocean Biomedical generated a negative expected return over the last 90 days | |
| Ocean Biomedical has high historical volatility and very poor performance | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (958.43 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations | |
| Ocean Biomedical has a poor financial position based on the latest SEC disclosures | |
| About 72.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from seekingalpha.com: Ocean Biomedical receives notice from Nasdaq regarding late filing |
Ocean Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ocean Stock often depends not only on the future outlook of the current and potential Ocean Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ocean Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.5 M | |
| Cash And Short Term Investments | 328.3 K |
Ocean Biomedical Technical Analysis
Ocean Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Ocean Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ocean Biomedical. In general, you should focus on analyzing Ocean Stock price patterns and their correlations with different microeconomic environments and drivers.
Ocean Biomedical Predictive Forecast Models
Ocean Biomedical's time-series forecasting models is one of many Ocean Biomedical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ocean Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ocean Biomedical
Checking the ongoing alerts about Ocean Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ocean Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ocean Biomedical generated a negative expected return over the last 90 days | |
| Ocean Biomedical has high historical volatility and very poor performance | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (958.43 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations | |
| Ocean Biomedical has a poor financial position based on the latest SEC disclosures | |
| About 72.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from seekingalpha.com: Ocean Biomedical receives notice from Nasdaq regarding late filing |
Check out Ocean Biomedical Backtesting, Ocean Biomedical Valuation, Ocean Biomedical Correlation, Ocean Biomedical Hype Analysis, Ocean Biomedical Volatility, Ocean Biomedical History as well as Ocean Biomedical Performance. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Return On Assets (6.82) |
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.